BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16682383)

  • 21. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
    Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HFE mutations and risk of coronary heart disease in middle-aged women.
    van der A DL; Peeters PH; Grobbee DE; Roest M; Marx JJ; Voorbij HM; van der Schouw YT
    Eur J Clin Invest; 2006 Oct; 36(10):682-90. PubMed ID: 16968463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events.
    Loew M; Hoffmann MM; Koenig W; Brenner H; Rothenbacher D
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1470-4. PubMed ID: 15860739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
    Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
    Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors.
    Dehghan A; van Hoek M; Sijbrands EJ; Stijnen T; Hofman A; Witteman JC
    Diabetes Care; 2007 Oct; 30(10):2695-9. PubMed ID: 17623828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.
    Boekhoorn SS; Isaacs A; Uitterlinden AG; van Duijn CM; Hofman A; de Jong PT; Vingerling JR
    Ophthalmology; 2008 Nov; 115(11):1899-903. PubMed ID: 18708255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
    Palmieri L; Donfrancesco C; Giampaoli S; Trojani M; Panico S; Vanuzzo D; Pilotto L; Cesana G; Ferrario M; Chiodini P; Sega R; Stamler J
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):562-70. PubMed ID: 16874146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease.
    Asselbergs FW; Pai JK; Rexrode KM; Hunter DJ; Rimm EB
    Clin Sci (Lond); 2007 Mar; 112(5):291-8. PubMed ID: 17040205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study.
    Reitz C; Berger K; de Maat MP; Stoll M; Friedrichs F; Kardys I; Witteman JC; Breteler MM
    Stroke; 2007 Aug; 38(8):2356-9. PubMed ID: 17600233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies.
    Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
    PLoS One; 2008 Jan; 3(1):e1395. PubMed ID: 18167554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.